Roper Technologies, Inc. Profile Avatar - Palmy Investing

Roper Technologies, Inc.

Roper Technologies, Inc. designs and develops software, and engineered products and solutions. The company offers management, campus solutions, diagnostic and laboratory information management, enterprise management, information solutions, transportation…
Industrial - Machinery
US, Sarasota [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 17% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 1.11 98.83 97.75
Graham Fair Price < 0.005 115.59 115.59
PEG 810.61 34.21 3.76
Price/Book -0.37 3.33 3.34
Price/Cash Flow 15.07 115.56 100.43
Prices/Earnings 3.51 38.77 37.45
Price/Sales -2.42 35.25 36.12
Price/FCF 15.07 115.56 100.43
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 0.76 0.70 0.70
Operating Margin -0.16 0.29 0.29
ROA -7.73 0.01 0.01
ROE 0.02 0.02 -3.75
ROIC 0.02 0.01 -3.42
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.22 -0.08 175.89
Dividends QOQ < 0.005 0.11 5579.35
EBIT QOQ 0.04 0.04 6.78
EPS QOQ 0.10 0.01 -88.63
FCF QOQ -0.05 -0.12 -158.75
Revenue QOQ 0.03 0.04 29.97
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 21.86 22.69 3.82
Days Sales Outstanding (DSO) 54.89 48.56 -11.52
Inventory Turnover 4.12 3.97 -3.68
Debt/Capitalization 0.27 0.30 13.65
Quick Ratio 0.40 0.38 -6.06
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 163.19 166.33 1.93
Cash 2.00 1.85 -7.51
Capex -0.39 -0.18 54.50
Free Cash Flow 5.43 4.79 -11.75
Revenue 15.09 15.71 4.07
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 0.50 0.49 -1.98
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 9.28 11.14 19.98
Naive Interpretation Member
06 - Financial Health · Bad
End of ROP's Analysis
CIK: 882835 CUSIP: 776696106 ISIN: US7766961061 LEI: - UEI: -
Secondary Listings